LENZ Therapeutics, Inc.

LENZ
$5.89 (+ $0.10 + 1.73%)
Last updated: 2026-07-06 00:21 UTC
LENZ Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS38870X1046
CUSIP38870X104
Market Price5.89
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyMonthly
P/E RatioN/A
EPS-2.06
Market Cap$536.3M
Book Value6.78
Price to Book2.527
BetaN/A
52w High50.4
52w Low15.7
Next Earnings DateN/A

LENZ Therapeutics, Inc. trades under ticker LENZ on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US38870X1046, CUSIP 38870X104.

About the Company
LENZ Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.
Price History